Author

Sara Linker Nord

Observed names: S. J. Linker Nord, S. L. Nord, S. Linker Nord, Sara J. Linker Nord, Sara Linker-Nord

Observed institutions: Mayo Clinic, NGM Biopharmaceuticals (United States)

OpenAlex ID: A5082847181

Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion

2009 · M. Camilleri, A. Nadeau, et al. · Neurogastroenterology & Motility · 126

Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?

2009 · Seth Sweetser, Michael Camilleri, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 114

Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis

2011 · D. L. Francis, A. Foxx‐Orenstein, et al. · Alimentary Pharmacology & Therapeutics · 99

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome

2016 · Andrés Acosta, Michael Camilleri, et al. · Clinical and Translational Gastroenterology · 88

Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes

2020 · Gerardo Calderon, Alison McRae, et al. · EBioMedicine · 83

PDF

Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers

2016 · A. D. Nelson, M. Camilleri, et al. · Neurogastroenterology & Motility · 57

Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea

2020 · Michael Camilleri, Sara Linker Nord, et al. · Alimentary Pharmacology & Therapeutics · 45

Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial

2020 · Priya Vijayvargiya, Michael Camilleri, et al. · Clinical Gastroenterology and Hepatology · 45

Randomised clinical trial: the effects of d aikenchuto, TU ‐100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation

2013 · J. Iturrino, M. Camilleri, et al. · Alimentary Pharmacology & Therapeutics · 41

Open: Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial

2018 · Ibironke Oduyebo, Michael Camilleri, et al. · The American Journal of Gastroenterology · 36

A Preliminary Candidate Genotype–Intermediate Phenotype Study of Satiation and Gastric Motor Function in Obesity

2009 · Athanasios Papathanasopoulos, Michael Camilleri, et al. · Obesity · 17

A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome

2015 · Andres Acosta, Michael Camilleri, et al. · Journal of Neurogastroenterology and Motility · 7

PDF

T1405 Effects of a Novel Corticotrophin Releasing Factor Receptor-1 Antagonist, BMS-562086, On Gastrointestinal and Colonic Transit and Bowel Habits in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

2008 · Seth R. Sweetser, Sara J. Linker Nord, et al. · Gastroenterology · 7

Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study

2022 · Priya Vijayvargiya, Margaret Breen-Lyles, et al. · Digestive Diseases and Sciences · 6

976 – A Double-Blind, Randomized, Placebo-Controlled, Crossover, Multiple-Dose Study of Tropifexor, a Non Bile Acid Fxr Agonist, in Patients with Primary Bile Acid Diarrhea

2019 · Michael Camilleri, Sara Linker Nord, et al. · Gastroenterology · 5

Tu1793 Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome: A Randomized, Double-Blinded Trial

2016 · Andres Acosta, Michael Camilleri, et al. · Gastroenterology · 3

NGM282, Variant of FGF19, is a Gastric and Colonic Prokinetic and Stimulates Bowel Function in Patients with Functional Constipation: Phase 1B, Two-Dose, Placebocontrolled Study

2017 · Ibironke Oduyebo, Alfred D. Nelson, et al. · Gastroenterology · 2

The Role of GERD in Eosinophilic Esophagitis

2011 · Dawn L. Francis, Amindra S. Arora, et al. · Gastroenterology · 2

Mo1589 A Single-Center, Placebo-Controlled, Double-Blind Study to Evaluate the Effects of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation, and Distal Gastric Function in Healthy Volunteers

2016 · Alfred D. Nelson, Michael Camilleri, et al. · Gastroenterology · 1

S535 An Open-Label Comparison Study of Eluxadoline in Participants with Irritable Bowel Syndrome with Diarrhea Who Have Evidence of Bile Acid Malabsorption

2021 · Michael Camilleri, Priya Vijayvargiya, et al. · The American Journal of Gastroenterology

A Randomized Controlled Trial of a Farnesoid X Receptor Agonist, Tropifexor, in Patients with Primary Bile Acid Diarrhea

2020 · Michael Camilleri, Sara Linker Nord, et al. · The Novartis Repository (Novartis)

Ileo-Colonic Delivery of Conjugated Bile Acids Improves Glucose Homeostasis via Colonic GLP-1-Producing Enteroendocrine Cells in Human Obesity and Diabetes

2020 · Gerardo Calderon, Alison McRae, et al. · SSRN Electronic Journal

1132 Establishment and Validation of a New Protocol and Normative Values for the Evaluation of Gastric Emptying and Gastric Accommodation in Bariatric Surgery Patients

2019 · Xiao Jing Wang, Eric J. Vargas, et al. · The American Journal of Gastroenterology

446 – Modulation of Bile Acids Pathway in Obesity and Type 2 Diabetes

2019 · Gerardo Calderon, Alison N. Bonis, et al. · Gastroenterology

PDF

A Klothoβ Variant Is Associated With Colonic Transit in Patients With Functional Constipation Treated With NGM282, a Novel FGF19 Analog: Phase 1B, 2 Dose, Placebo-Controlled Study

2017 · Ibironke Oduyebo, Alfred D. Nelson, et al. · The American Journal of Gastroenterology

Works count: 26

Citation count: 784

H-index: 11

I10-index: 11